ASH 2015 | Identification of high-risk disease using molecular profiling by Mymap
Gareth Morgan, MD, FRCP, FRCPath, PhD from the University of Arkansas for Medical Sciences, Arkansas, AR talks about gene expression analysis in multiple myeloma (MM), which can help determine the prognosis of the disease based on different molecular sub-groups. The Arkansas group has developed a simple test that can help identify the genetic markers of high-risk MM, called Mymap. The data was presented at the American Society of Hematology (ASH) 2015 Annual Meeting, held in Orlando, FL.
Get great new content delivered to your inboxSign up